Skip to Content
MDPIMDPI
ARMAdvances in Respiratory Medicine
PDF
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Case Report
  • Open Access

8 September 2015

Interstitial Lung Disease Associated with Docetaxel in a Patient Treated for Breast Cancer—A Case Report

,
,
and
1
XI Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, ul. Płocka 26, 01-138 Warsaw, Poland
2
III Department of Lung Diseases, National Institute of Tuberculosis and Lung Diseases, ul. Płocka 26, 01-138 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med.2015, 83(5), 378-382;https://doi.org/10.5603/PiAP.2015.0060
Version Notes
Order Reprints

Abstract

Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibits normal interphase and mitotic cellular function, causing cell death. Docetaxel is indicated for the treatment of breast, lung and prostate cancers, head and neck cancer and gastric adenocarcinoma. Interstitial pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced interstitial lung disease (ILD) in a patient with breast cancer.

Article Metrics

Citations

Article Access Statistics

Journal Statistics
Multiple requests from the same IP address are counted as one view.
Usage and Usability of One Dry Powder Inhaler Compared to Other Inhalers at Therapy Start: An Open, Non-interventional Observational Study in Poland and Germany
Previous
Chronic Pneumonia Due to Klebsiella oxytoca Mimicking Pulmonary Tuberculosis
Next